WALTHAM, MA
--
EyeGate Pharma has announced the
relocation of its executive team to Waltham,
MA, according to a company
spokesman.
The company, which is developing ocular treatments by using iontophoretic
technology to deliver therapeutics to chambers of the eye, was previously
located in Paris, France.
EyeGate will operate from a 12,200 square foot office and lab space with a
staff of 15 people.